申请人:YM Biosciences Australia Pty Ltd
公开号:US20130274263A1
公开(公告)日:2013-10-17
Compounds of general formula (I), (II), (III) and (V) are described for use in modulating microtubule polymerisation and in the treatment of associated disease states. Use of compounds (I), (III) and (V) in the treatment of kinase-associated disease states is also described. Further described are novel compounds of formula (II), (III) and (V).
本文描述了通式(I)、(II)、(III)和(V)的化合物,用于调节微管聚合并治疗相关疾病状态。还描述了化合物(I)、(III)和(V)在治疗激酶相关疾病状态中的用途。此外还描述了新的通式(II)、(III)和(V)的化合物。